MarginsXMarginsX
Home › Markets › Health Care › ICUI

ICU Medical Inc. (ICUI)

ICUI trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$181.87
+1.45% on the day
Market cap
$4.5B
Mid cap
Revenue · 2025
$2.2B
-6.3% on 2024
Net income · 2025
$732K
0.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/883984/000088398426000008/0000883984-26-000008-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerICUI on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year1992
SEC CIK0000883984
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$2.2B
Net income$732K
Operating income$42.8M
Net margin0.0%
Operating margin1.9%
Revenue growth-6.3%
Cash$308.0M
Total assets$4.1B
P/E (computed)6213.9×
P/S (computed)2.0×

Warning signs

Cash runway
Cash-flow positive
$301.8M cash at September 30, 2026
Share count, 1 year
+1.3%
2025-10-31 to 2026-10-31 · +3.6% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$8.3M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$301.8M cash; operating cash flow $69.8M a quarter.Report 2026-09-30
Shares outstanding25,010,099 (2026-10-31); 24,686,660 a year earlier; 24,140,076 three years earlier.Cover page 2026-10-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, Costa Mesa, California, United StatesPCAOB Form AP 2026-03-03
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $8.3M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$560.4M$26.8M$99.6M$301.8M$1.2B$2.2B10-Q 2026-11-05
Q2 2026
2026-06-30
$551.7M$19.1M$80.2M$298.3M$1.2B$2.2B10-Q 2026-08-06
Q1 2026
2026-03-31
$530.2M$30.1M$38.9M$288.3M$1.3B$2.2B10-Q 2026-05-07
Q4 2025
2025-12-31
$540.7MNot filed$60.6M$308.0M$1.3B$2.2B10-K 2026-02-19
Q3 2025
2025-09-30
$537.0M-$3.4M$56.7M$299.7M$1.3B$2.3B10-Q 2026-11-05
Q2 2025
2025-06-30
$548.9M$35.3M$11.2M$300.0M$1.3B$2.4B10-Q 2026-08-06
Q1 2025
2025-03-31
$604.7M-$15.5M$51.3M$289.7M$1.5B$2.4B10-Q 2026-05-07
Q4 2024
2024-12-31
$629.8MNot filed$40.2M$308.6M$1.6B$2.4B10-K 2026-02-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2023-03-03
Latest annual report10-K2026-02-19
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxyDEFA14A2026-04-02

Source: SEC EDGAR submissions feed, 1,003 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+4.2%
1 month+9.8%
3 months-2.1%
Year to date+25.7%
1 year+29.4%
From 52-week high-4.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
STVNStevanato Group S.p.A.$15.53-1.71%$4.2B
HTFLHeartflow Inc.$46.86-3.30%$4.1B
MMSIMerit Medical Systems Inc.$86.35-0.32%$5.2B
MMEDMiniMed Group Inc.$18.65+3.67%$5.2B
NVSTEnvista Holdings Corporation$24.03-1.88%$3.9B
HAEHaemonetics Corporation$121.34-1.30%$5.5B
PLSEPulse Biosciences Inc Common Stock (DE)$46.36-8.09%$3.4B
TFXTeleflex Incorporated$157.10+1.51%$6.2B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier